In this
issue.....
Articles:
Features:
ASCO
2007
Research Advocacy
Network
will be accepting
applications for the 2007 Focus on Research Course in preparation for the ASCO Annual Meeting. This year's course will feature a
robust
schedule of web lectures on the Genomics Module. Classes on Clinical Trial Design will also be
included. Watch your inbox for a notice
within the next 5 days to download the application.
IVDMIA
Guidance Comments Due March 5
The Food and Drug Administration (FDA) held a public meeting on In Vitro
Diagnostic Multivariate Index Assays on February 8th. The FDA panel heard
presentations and comments from 32 stakeholders regarding the draft guidance
entitled "Draft Guidance for Industry, Clinical Laboratories, and FDA
Staff on In Vitro Diagnostic Multivariate Index Assays." This draft
guidance is intended to provide clarification on FDA's approach to regulation
of in vitro diagnostic multivariate index assays.
Two days
prior, the FDA approved the Mammaprint test as an IVDMIA through a de novo
510K. However, comments on the draft guidance on this classification and
process for approving the category of test does not close until March 5.
The
presentations by over thirty stakeholders represented a broad range of
viewpoints. Elda Railey, co-founder of RAN, was one of the presenters.
RAN's presentation as well as the comments we have filed for the draft guidance
can be accessed here (RAN
Presentation) (RAN
Comments on Draft Guidance IVDMIA).
Return to "In this
issue....."
From
the ASCO
Expert Corner: Research Highlights From the 2007 Prostate Cancer Symposium
Leading
experts in prostate cancer recently met in Orlando, Fla
at the 2007 Prostate Cancer Symposium to present and discuss new research
related to the prevention, screening, and treatment of prostate cancer. Cosponsors
of the symposium included the American Society of Clinical Oncology (ASCO),
American Society for Therapeutic Radiology and Oncology (ASTRO), and the
Society of Urologic Oncology (SUO). Click here to read the full text of this article.
Return to "In this
issue....."
Disparities in Colon Cancer Screening
Remain Among Medicare Patients
CHICAGO--Although Medicare coverage for colorectal cancer screening has
increased, there are still significant disparities in screening practices by
ethnicity, sex, age, education and income level, according to a report in the
February 12, 2007 issue of the Archives of Internal Medicine, one of the
JAMA/Archives journals.
Colorectal
cancer is the third most common cancer affecting men and women in the United States
with approximately 145,290 new cases in 2005, according to background
information in the article. "There is evidence that screening for
colorectal cancer decreases incidence and mortality from the disease," the
authors write. Please link to the National Colorectal Cancer Roundtable for the
full article 2/12/2007 Arch Intern Med. 2007 http://www.nccrt.org/News/NewsDetail.aspx?article_id=490.
March is
Colorectal Cancer
Awareness Month
OncoLink and
National Colorectal
Cancer Research Alliance
Colorectal Cancer SurveyThis
confidential survey was developed by cancer experts as an interactive way to
help leading scientists study families with a history of colorectal cancer. http://www.oncolink.org/nccra/survey_intro.cfm
Research Advocacy
Network Announces Availability of New Publications
Genomics
Module
The Research Advocacy
Network has introduced a new education module for advocates interested in
learning more about genetics and genomics and the role of this emerging field
in cancer research. The module
covers the science behind genomics, including scientific concepts and examples
of how genomic technology is currently being incorporated into clinical
research. To help bring this information to life, the module also includes
basic definitions, diagrams, and graphics - all in an effort to de-mystify the
science and technology. The module was supported by an educational grant from
Genomic Health. To order the printed workbook click for the Genomics
Module Order Form
Tissue Donation
for Research Education Booklets
Research Advocacy Network has
developed booklets for prospective donors and institutional review boards to
understand the importance and implications of donating tissue for research
purposes. Thanks to a grant from Eli Lilly and Company, we have been able
to reprint these booklets and they are now available in English and Spanish for
your use. Please click here to access the Tissue
Booklets Order Form.
Return to "In this
issue....."
Research Advocacy
Network
Activities
and
Events of Interest to Research Advocates
2007
March 14-18, 2007 National
Comprehensive Cancer Network Annual Conference,
Ft. Lauderdale, FL
www.nccn.org
March 26-27,
2007 NCI meeting "Preoperative Therapy in Invasive Breast
Cancer: Reviewing
the State of the Science
and
Exploring New Research
Directions"
http://ctep.cancer.gov/bcmeeting
April 14-18,
2007 American Association of Cancer
Research, Los Angeles, CA www.aacr.org
April 17 - 20,
2007 North Central Cancer Treatment Group Meeting
April 24-27,
2007 Oncology Nursing Society, Las Vegas, NV
June 1- 5,
2007 American
Society of Clinical Oncology, Chicago,
IL www.asco.org
Also of interest:
We need your help!
Your Donation Makes a Difference! If you believe in the hope of research
and the power of advocacy, you can help the Research Advocacy Network (RAN) by
sending a donation. RAN is an exempt 501 c 3 organization and dependent on your
support to keep going.
PLEASE NOTE our new
mailing address is: 6505 W. Park
Blvd, Suite 305, PMB 220, Plano, TX 75093. Thanks!
Return to "In this
issue....."
Research Advocacy
Network Welcomes New Members!!! Thanks to all of you who
have recently joined
the Network. For those that have not yet please go to http://www.researchadvocacy.org/
and click on "Join" There are no dues for Network membership and this
will assure that you receive all notices and have access to Network programs.
Editor: Elda Railey
Network News is
currently published 10 times per year and includes articles on advocacy,
research results and activities. Please share Network News with your
friends with the link above. Research Advocacy Network is an Illinois not-for-profit corporation and is
designated as an exempt 501 c 3 organization by the IRS. Your donations are
greatly appreciated and tax deductible to the extent allowed by law.
Return to "In this
issue....."
